Quimioterapia
Todos los tratamientos
Ankara
Todos los países
Seleccionar una ciudad
Quimioterapia
Todos los tratamientos
Ankara
Todos los países
Seleccionar una ciudad

Los mejores oncohematólogos de Quimioterapia en Ankara — TOP-4 médicos

El contenido cumple con la Política editorial de Bookimed y está revisado médicamente por
Fahad Mawlood - Médico general. Ganador de 4 premios científicos. Sirvió en Asia Occidental. Es el ex jefe del equipo médico que soporta a pacientes de habla árabe. Ahora es responsable del procesamiento de datos y la precisión del contenido médico.
Emrah Eraslan
Oncólogo clínico
19 años de experiencia
Turquía, Ankara
Private Koru Ankara Hospital

Emrah Eraslan

Oncólogo clínico
19 años de experiencia

Associate Professor Dr. Emrah Eraslan graduated from Ankara University Faculty of Medicine in 2005. From 2006 to 2011, he worked as a research assistant in the Department of Internal Medicine at Ankara University Faculty of Medicine and became an internal medicine specialist in 2011. Between 2011 and 2013, he worked as an internal medicine specialist and chief physician at Dr. Nafiz Körez Sincan State Hospital and Palu District State Hospital. From 2013 to 2016, he received medical oncology training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital and worked there until 2021. In 2023, he became an associate professor and contributed to his field with his publications throughout his career. He currently serves his patients at Koru Ankara Hospital. His medical interests include:

Breast Cancer

Prostate Cancer

Lung Cancer

Colorectal Cancer

Stomach Cancer

Ovarian Cancer

Mostrar más

Associate Professor Dr. Emrah Eraslan graduated from Ankara University Faculty of Medicine in 2005. From 2006 to 2011, he worked as a research assistant in the Department of Internal Medicine at Ankara University Faculty of Medicine and became an internal medicine specialist in 2011. Between 2011 and 2013, he worked as an internal medicine specialist and chief physician at Dr. Nafiz Körez Sincan State Hospital and Palu District State Hospital. From 2013 to 2016, he received medical oncology training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital and worked there until 2021. In 2023, he became an associate professor and contributed to his field with his publications throughout his career. He currently serves his patients at Koru Ankara Hospital. His medical interests include:

Breast Cancer

Prostate Cancer

Lung Cancer

Colorectal Cancer

Stomach Cancer

Ovarian Cancer

Mostrar más
Osman Ilhan
Hematólogo
46 años de experiencia
Turquía, Ankara
Private Koru Ankara Hospital

Osman Ilhan

Hematólogo
46 años de experiencia

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Mostrar más

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Mostrar más
Yusuf Acikgoz
Oncólogo clínico
8 años de experiencia
4.5
3 reseñas
Turquía, Ankara
Lokman Hekim University Ankara Hospital

Yusuf Acikgoz

Oncólogo clínico
8 años de experiencia

Profesor asociado Dr. Yusuf AÇIKGÖZ
Especialización: Oncología Médica

Educación:

  • 2004-2011: Facultad de Medicina de la Universidad de İnönü
  • 2011-2016: Hospital de Formación e Investigación Numune de Ankara, Medicina interna
  • 2017-2022: Universidad de Ciencias de la Salud, Oncología Médica

Experiencia Profesional:

  • 2016-2017: Hospital de la ciudad de Bingöl, Medicina interna
  • 2021-2022: Universidad de Ciencias de la Salud, Oncología Médica
  • 2022-2023: Hospital de Educación e Investigación de Kastamonu, Oncología Médica
  • 2023-2024: Universidad Estatal de Ohio, Oncología Médica
  • 2024-Presente: Universidad Lokman Hekim, Oncología Médica, Hospital de Ankara

Ensayos clínicos, cursos, certificaciones:

Ensayos clínicos:

  • 2017-2021: Fase III, estudio CheckMate-649 (investigador adjunto)
  • 2022-Presente: Fase III, estudio Fortitude-101 (investigador adjunto)

Cursos:

  • 2018: Programa de capacitación en bioestadística básica y avanzada de Medicres (en curso), Estambul-Viena
  • 2019: Curso de formación en inmunooncología, 1 y 2 de marzo de 2019, Viena, Centroeuropeo Cooperative Oncology Group (CECOG)
  • 2018: Certificación de Buenas Prácticas Clínicas, 7 y 8 de abril de 2018, Ankara, Universidad de Ciencias de la Salud
  • 2017: Programa de formación básica en oncología, 25 y 26 de noviembre de 2017, Adana, Sociedad de Oncología Clínica
  • 2016: Curso básico de ecografía (10 horas teóricas + 10 horas prácticas), 24 y 25 de septiembre de 2016, Ankara, Asociación Turca de Medicina de Emergencia

Certificaciones:

  • En curso: Certificación ECFMG
  • 2024: Conducta responsable de investigación de CITI (Universidad Estatal de Ohio)
  • 2024: CITI IACUC-Investigación con animales de laboratorio (Universidad Estatal de Ohio)
  • 2024: CITI Protección de sujetos humanos (Universidad Estatal de Ohio)
  • 2024: Buenas prácticas clínicas de CITI (Universidad Estatal de Ohio)
  • 2023: Prueba de inglés ocupacional (OET)
  • 2019: Sistema internacional de evaluación del idioma inglés (IELTS), puntuación total: 6,5, 26 de mayo de 2019, Ankara, British Council
  • 2017: Examen USMLE Step 2 CK; Puntuación: 244, 7 de febrero de 2017
  • 2016: Examen USMLE Paso 1; Puntuación: 215, 25 de agosto de 2016

Membresías:

  • Sociedad Estadounidense de Oncología Clínica (ASCO) - 2022
  • Sociedad Turca de Oncología Médica - 2020
Mostrar más

Profesor asociado Dr. Yusuf AÇIKGÖZ
Especialización: Oncología Médica

Educación:

  • 2004-2011: Facultad de Medicina de la Universidad de İnönü
  • 2011-2016: Hospital de Formación e Investigación Numune de Ankara, Medicina interna
  • 2017-2022: Universidad de Ciencias de la Salud, Oncología Médica

Experiencia Profesional:

  • 2016-2017: Hospital de la ciudad de Bingöl, Medicina interna
  • 2021-2022: Universidad de Ciencias de la Salud, Oncología Médica
  • 2022-2023: Hospital de Educación e Investigación de Kastamonu, Oncología Médica
  • 2023-2024: Universidad Estatal de Ohio, Oncología Médica
  • 2024-Presente: Universidad Lokman Hekim, Oncología Médica, Hospital de Ankara

Ensayos clínicos, cursos, certificaciones:

Ensayos clínicos:

  • 2017-2021: Fase III, estudio CheckMate-649 (investigador adjunto)
  • 2022-Presente: Fase III, estudio Fortitude-101 (investigador adjunto)

Cursos:

  • 2018: Programa de capacitación en bioestadística básica y avanzada de Medicres (en curso), Estambul-Viena
  • 2019: Curso de formación en inmunooncología, 1 y 2 de marzo de 2019, Viena, Centroeuropeo Cooperative Oncology Group (CECOG)
  • 2018: Certificación de Buenas Prácticas Clínicas, 7 y 8 de abril de 2018, Ankara, Universidad de Ciencias de la Salud
  • 2017: Programa de formación básica en oncología, 25 y 26 de noviembre de 2017, Adana, Sociedad de Oncología Clínica
  • 2016: Curso básico de ecografía (10 horas teóricas + 10 horas prácticas), 24 y 25 de septiembre de 2016, Ankara, Asociación Turca de Medicina de Emergencia

Certificaciones:

  • En curso: Certificación ECFMG
  • 2024: Conducta responsable de investigación de CITI (Universidad Estatal de Ohio)
  • 2024: CITI IACUC-Investigación con animales de laboratorio (Universidad Estatal de Ohio)
  • 2024: CITI Protección de sujetos humanos (Universidad Estatal de Ohio)
  • 2024: Buenas prácticas clínicas de CITI (Universidad Estatal de Ohio)
  • 2023: Prueba de inglés ocupacional (OET)
  • 2019: Sistema internacional de evaluación del idioma inglés (IELTS), puntuación total: 6,5, 26 de mayo de 2019, Ankara, British Council
  • 2017: Examen USMLE Step 2 CK; Puntuación: 244, 7 de febrero de 2017
  • 2016: Examen USMLE Paso 1; Puntuación: 215, 25 de agosto de 2016

Membresías:

  • Sociedad Estadounidense de Oncología Clínica (ASCO) - 2022
  • Sociedad Turca de Oncología Médica - 2020
Mostrar más
Esta página puede incluir información relacionada con diversas afecciones médicas, tratamientos y servicios de salud disponibles en diferentes países. Tenga en cuenta que el contenido se proporciona sólo con fines informativos y no debe interpretarse como asesoramiento médico o orientación. Por favor consulte con su médico o con un profesional médico calificado antes de comenzar o cambiar el tratamiento médico.